December 28, 2020 9:19 pm
Covid-19 Vaccine: "India will be given priority as a majority of the stockpiled 50 million doses at Serum Institute will be for the country," said Serum's Chief Executive Adar Poonawalla.
December 20, 2020 9:00 pm
According to Poonawalla, when “frivolous” claims crop up and are blown out of proportion, it affects the confidence of not just anti-vaxxers, but the general public too.
December 05, 2020 10:46 am
Pune-based Serum Institute of India (SII) has collaborated with the University of Oxford and the British-Swedish pharmaceutical company AstraZeneca for making the COVID-19 vaccine, ''Covidshield'', and is conducting trials in India.
November 14, 2020 1:10 pm
If final-stage trial data show AstraZeneca’s candidate gives effective protection from Covid-19, the Serum Institute of India may get emergency authorization from New Delhi by December, said Adar Poonawalla.